The expression of galectin (Gal)‐3, a key regulator of lung fibrosis, is raised in the lavage fluid and serum of the bronchi and alveoli of IPF patients, and this expression is further elevated during acute phases.90, 91. This evidence concerns the gene LGALS3 and pulmonary fibrosis.